Study supports efficacy of adalimumab for noninfectious uveitis

This phase 3 extension of the VISUAL trials evaluated the safety and efficacy of adalimumab in patients with noninfectious intermediate, posterior or panuveitis.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553